Colorectal cancer in a population with a guaiac-based screening programme;Cáncer colorrectal en una población con un programa de cribado basado en la prueba del guayaco

Medicina Clinica

Volumn 132, Issue 13, 2009, Pages 495-500

  Navarro, Matilde ^a   Peris, Mercè ^a   Binefa, Gemma ^a   Vanaclocha, Mercedes ^a   Losa, Ferran ^b   Fernández, Esteve ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL GENERAL DE CATALUNYA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Colorectal cancer; Guaiac based test; Interval cancer; Screening

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; POPULATION RESEARCH; SPAIN; SYMPTOM;

EID: 64649092652     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.12.026     Document Type: Article

References (31)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
2. o.5 version 2.0. Lyon: IARC Press; 2004.
3. Strong K., Wald N., Miller A., and Alwan A. Current concepts in screening for noncommunicable disease: World Health Organization Consultation Group report on methodology of noncommunicable disease screening. J Med Screen 12 (2005) 12-19
4. Cho K.R., and Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer 70 (1992) 1727-1731
5. Smith R.A., Cokkinides V., and Eyre H.J. American Cancer Society guidelines for the early detection of cancer. Cancer J Clin 53 (2003) 27-43
6. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 (2005) 1407-1427
7. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M., et al., Minnesota Colon Cancer Control Study. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Medicin 328 (1993) 1365-1371
8. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
9. Kronborg O., Fenger C., Olsen J., Jergensen O.D., and Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
10. Peris M., Espinás J.A., Muñoz L., Navarro M., Binefa G., and Borrás J.M. Lessons learned from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screening 14 (2007) 81-86
11. Mandel J.S., Church T.R., Bond J.H., Ederer F., Geisser M.S., Mongin S.J., et al. The effect of faecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
12. Smiljanic S., and Gill S. Patterns of diagnosis for colorectal cancer: Screening detected vs symptomatic presentation. Dis Colon Rectum (2008) 1-5
13. Cress R.D., Morris C., Ellison G.L., and Goodman M.T. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer 107 5 Suppl (2006) 1142-1152
14. Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European Union. Eur J Cancer 36 (2000) 1473-1478
15. Díaz-Rubio E., Ascunze Eliaga N., Borrás Andrés J.M., Cabezas Peña C., Expósito Hernández J., Guillem Porta V., et al. Estrategia en Cáncer del Sistema Nacional de Salud (2006), Ministerio de Sanidad y Consumo, Madrid
16. Tarraga P., Garcia-Olmo D., Celada A., Garcia-Molinero M., Divison J.A., and Casado C. Cribado del cáncer colorrectal por detección de sangre oculta en heces en una zona de salud controlada. Rev Esp Enferm Dig 91 (1999) 335-344
17. Courtier R., Casamitjana M., Macia F., Panadés A., Castells X., Gil M.J., et al. Participation in a colorectal cancer screening programme: influence of the method of contacting the target population. Eur J Cancer Prev 11 (2002) 209-213
18. McGregor E., Hilsden R.J., and Li F.X. Low uptake of colorectal cancer screening 3 years after release of National Recommendations for Screening. Am J Gastroenterol 102 (2007) 1727-1735
19. Hakama M., Coleman M.P., Alexe D.M., and Auvinen A. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 44 (2008) 1404-1413
20. Benson V.S., Patnick J., Davies A.K., Nadel M.R., Smith R.A., and Atkin W.S. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer 122 (2008) 1357-1367
21. Vernon S.W. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89 (1997) 1406-1422
22. Farmer M.M., Bastani R., Kwan L., Belman M., and Ganz P.A. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer 112 (2008) 1230-1238
23. Guerra C., Schwartz J.S., Armstrong K., Brown J.S., Halbert C.H., and Shea J.A. Barriers of and facilitators to physician recommendation of colorectal cancer screening. J Gen Int Med 22 (2007) 1681-1688
24. Sewitch M.J., Fournier C., Ciampi A., and Dyachanko A. Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterol 7 (2007) 39-47
25. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: A systematic review for the US Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
26. Lang K., Lines L.M., Lee D.W., Korn J.R., Vanness D.J., Earle C.C., et al. Excess lifetime costs associated with colorectal cancer among elderly Medicare beneficiaries: Evidence from SEER-Medicare data [abstract 4044]. Proc ASCO. J Clin Oncol. 26 Supl (2008)
27. Ouyang D.L., Chen J.J., Getzenberg R.H., and Shoen R.E. Noninvasive testing for colorectal cancer: A review. Am J Gastroenterol 100 (2005) 1393-1403
28. Guittet L., Bouvier V., Mariotte N., Vallee J.P., Arsene D., Boutreux S., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56 (2007) 210-214
29. Van Rossum L.G., Van Rijn A.F., Laheij R.J., Van Oijen M.G., Fockens P., Van Krieken H.H., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterol 135 (2008) 82-90
30. Tazi M.A., Faivre J., Lejeune C., Bolard P., Phelip J.M., and Benhamiche A.M. Interval cancers in a community-based programme of colorectal cancer screening with faecal occult blood test. Eu J Cancer Prev 8 (1999) 131-135
31. World Health Organisation. IARC. 2000-2004. Disponible en: http://www.who.int/whosis/en/.